SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-21-042156
Filing Date
2021-12-17
Accepted
2021-12-17 09:24:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA 14A brhc10032002_defa14a.htm DEFA14A 19073
  Complete submission text file 0001140361-21-042156.txt   20227
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37853 | Film No.: 211499825
SIC: 2834 Pharmaceutical Preparations